Replies to post #231994 on NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

SNO 2018
The top 100 patients – 30% of all patients in the trial – have a Kaplan Meier median survival of 58.4 months.

That means that 50 patients will live 58.4 months or longer.

June 2019 ASCO
Marnix Bosch may be telegraphing that 20% of the ITT group of 331 patients will live 60 months or more.

50/66= 32% improvement.